After Leqembi approval, Eisai CEO to retire

Less than a week after Eisai secured a full approval for Leqembi — the first Alzheimer’s drug to achieve full approval — the drugmaker’s CEO announced his plan to retire by the end of July. 

Advertisement

Ivan Cheung, the CEO, president, senior vice president and chair of Eisai, will retire by July 31, according to a July 11 news release. Five executives were promoted, including Tatsuyuki Yasuno, who was CFO and is now acting president of the Americas and CEO and senior vice president of Eisai.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.